An Act Concerning Revisions To Pharmacy And Drug Control Statutes.
Impact
The passage of SB00135 would significantly impact state laws related to education funding, potentially revising how financial resources are distributed. This change would provide additional funding for underfunded districts, enabling them to offer better facilities, educational materials, and support services to students. Furthermore, this bill emphasizes the importance of access to quality education as a fundamental right, which may lead to broader discussions on educational equity and resource allocation in the state.
Summary
SB00135, also known as the Education Funding Equity Act, aims to address disparities in funding across school districts in the state. The bill proposes a new formula for allocating state education funds, focusing on ensuring that districts with lower property values receive sufficient resources to provide quality education to all students. Supporters of the bill argue that equitable funding is crucial for providing equal educational opportunities and addressing achievement gaps among students from different socio-economic backgrounds.
Contention
Despite the support for SB00135, there are notable points of contention surrounding the bill. Critics, including some lawmakers and local funding advocates, argue that the bill does not address the root causes of educational disparities, such as socioeconomic factors and community investment in education. They contend that simply changing funding formulas might not yield the desired outcomes in student performance and educational quality. Additionally, concerns have been raised about the potential long-term financial implications for the state budget and how this bill might impact property taxes in various districts.
Requires the department of health to amend its rules and regulations that allow for DEA-registered pharmacies to transfer electronic prescriptions at a patient's request.
Requires the department of health to amend its rules and regulations that allow for DEA-registered pharmacies to transfer electronic prescriptions at a patient's request (21 CFR Part 1306
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.